CIK 0000051253 · Large accelerated filer
INTERNATIONAL FLAVORS & FRAGRANCES INC
Sign in to watch- Ticker
- IFF
- Exchange
- NYSE
- Industry
- Industrial Organic Chemicals
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 131432060
- Phone
- 212-765-5500
- Business address
- 521 W 57TH ST, NEW YORK, NY, 10019
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-01 | Arora Yuvraj President, Taste & CCO | Shares withheld for taxes | −1,828 | $70.81 | $129K | 17,283 |
| 2026-05-01 | Arora Yuvraj President, Taste & CCO | Option exercise · Restricted Stock Units | −3,572 | 25,962 | ||
| 2026-04-29 | Willoughby Dawn C Director | Grant or award · Restricted Stock Units | +2,903 | 2,903 | ||
| 2026-04-29 | JAMISON CYNTHIA T Director | Grant or award · Restricted Stock Units | +2,903 | 2,903 | ||
| 2026-04-29 | Khan Mehmood Director | Grant or award · Restricted Stock Units | +2,903 | 2,903 | ||
| 2026-04-29 | O'Byrne Kevin Director | Grant or award · Restricted Stock Units | +4,839 | 4,839 | ||
| 2026-04-29 | Mulligan Richard Director | Grant or award · Restricted Stock Units | +2,903 | 2,903 | ||
| 2026-04-29 | Mantas Jesus B Director | Grant or award · Restricted Stock Units | +2,903 | 2,903 | ||
| 2026-04-29 | ICAHN BRETT Director | Grant or award · Restricted Stock Units | +2,903 | 2,903 | ||
| 2026-04-29 | FRIBOURG PAUL J Director | Grant or award · Restricted Stock Units | +2,903 | 2,903 | ||
| 2026-04-29 | Drosos Virginia Director | Grant or award · Restricted Stock Units | +2,903 | 2,903 | ||
| 2026-04-01 | Fyrwald J Erik Chief Executive Officer | Option exercise | +18,769 | 110,399 | ||
| 2026-04-01 | Fyrwald J Erik Chief Executive Officer | Shares withheld for taxes | −8,835 | $72.57 | $641K | 101,564 |
| 2026-04-01 | Fyrwald J Erik Chief Executive Officer | Grant or award · Restricted Stock Units | +66,143 | 154,202 | ||
| 2026-04-01 | Fyrwald J Erik Chief Executive Officer | Option exercise · Restricted Stock Units | −18,769 | $72.57 | $1.4M | 135,433 |
| 2026-04-01 | Finzel Ralf EVP, Global Operations Officer | Option exercise | +2,152 | 17,011 | ||
| 2026-04-01 | Finzel Ralf EVP, Global Operations Officer | Shares withheld for taxes | −868 | $72.57 | $63K | 16,143 |
| 2026-04-01 | Finzel Ralf EVP, Global Operations Officer | Grant or award · Restricted Stock Units | +6,890 | 18,642 | ||
| 2026-04-01 | Finzel Ralf EVP, Global Operations Officer | Option exercise · Restricted Stock Units | −2,152 | $72.57 | $156K | 16,490 |
| 2026-04-01 | Lourenco Leticia Goncalves President, Health & Bioscience | Option exercise | +4,305 | 4,305 |
Page 4 of 13 · 260 trades